News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

American Kidney Fund Applauds Introduction of the CARE for All Kidneys Act of 2021

American Kidney Fund

The American Kidney Fund (AKF) applauds Reps. Lisa Blunt Rochester (D-DE) and Brad Wenstrup (R-OH) for introducing the Coordination, Accountability, Research and Equity for All Kidneys Act of 2021, also known as the CARE for All Kidneys Act of 2021 (H.R. 3893). The bill would create a national action plan to address kidney disease in historically underserved populations, including minority and rural communities. LaVarne A. Burton, president and CEO of the American Kidney Fund, today issued this statement: “Kidney disease is one of the top 10 leading causes of death in the United States. Communities of color are disproportionately impacted by kidney failure, and underserved and rural communities face issues accessing health care. This important bill will pinpoint the issues that have created such a burden of kidney disease in these communities and will develop steps needed to prevent kidney disease, delay progression to kidney failure and increase the number of kidney transplants. “People living in underserved and rural communities have long faced challenges accessing health insurance, primary care, preventive care and pre-dialysis nephrology care. AKF is proud to have worked closely with Reps. Blunt Rochester and Wenstrup to develop a bill that aims to improve the health care delivery system, making it more equitable, accessible and inclusive, and to ensure high quality care for all kidney disease patients. “The CARE for All Kidneys Act of 2021 would create a national action plan that brings together key stakeholders, including the National Institutes of Health (NIH), the National Institute of Diabetes and Digestive and Kidney Diseases at NIH and the Centers for Disease Control and Prevention to address health disparities in kidney disease. The bill would support initiatives like expanding ongoing kidney disease research and addressing lower kidney transplantation rates in underserved communities. “This legislation is vital in addressing health disparities, improving the social determinants of health in the U.S. and ensuring that all kidney patients have access to the care they need. The introduction of this bill is just the first step. AKF is urging other members of Congress to cosponsor this important legislation to help it advance.” About the American Kidney Fund The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation’s leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. AKF is one of the nation’s top-rated nonprofits, investing 97 cents of every donated dollar in programs, and holds the highest 4-Star rating from Charity Navigator and the Platinum Seal of Transparency from GuideStar. For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn. Contact Details American Kidney Fund Elissa Blattman +1 301-984-6644 eblattman@kidneyfund.org Company Website http://www.kidneyfund.org/

June 17, 2021 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Cyvatar Raises an Additional $9 Million in Series A Round

Cyvatar

Cyvatar today announced that it has raised $9 million as part of its Series A financing to help scale and serve its rapidly growing customer base and continue to drive the adoption of its innovative cybersecurity-as-a-service (CSaaS) model. Escalating cybersecurity breaches and the need to address vulnerabilities across systems, networks, and apps fuel the security services market, expected to reach $193 billion by 2028. Additionally, the growth in hybrid and remote workers coupled with unsecured and unpatched BYOD devices further underscores the need for on-demand cybersecurity resources that include human talent, proven processes, and best-of-breed technology delivered from a single intuitive platform. Cyvatar has grown more than 200% since its debut in October. ATX Venture Partners led the round with additional participation from existing customer CORTEC and longtime Cyvatar investor Bill Wood Ventures. Cyvatar closed a $3 million seed round late last year, bringing the total amount raised over the last eight months to $12 million. “We’ve seen fundraising explode in the security space, in part as a result of the raft of ransomware, email compromise, and phishing attacks that have made people more aware of the problem and increased the need to fix it quickly and effectively,” said Chris Shonk, partner at ATX Venture Partners. “Cyvatar is an exciting addition to our dynamic portfolio and a natural fit alongside our other rapidly growing organizations. No other company we evaluated solves the problems of cybersecurity like Cyvatar. With Cyvatar CSaaS, security becomes as effortless as turning on the lights. There’s no better value for customers.” Cyvatar CSaaS offers security in a box for organizations of any size and any level of cybersecurity expertise--already more than 150 platform members have started the security journey with Cyvatar. Its mature sales and marketing engine makes it easy for new members to join and offers ongoing education and support for existing customers to continuously remediate evolving threats, safeguard critical systems, and boost compliance scores. "I can tell you that after implementing just three Cyvatar solutions, our security confidence is a lot stronger than it was before and our company as a whole is far more secure,” said Brent Fanguy, vice president of technology at CORTEC. “We applaud Cyvatar for pricing by employee count because it’s so easy to calculate and fit into our budget -- no counting servers or workstations, which is a nightmare. Cyvatar has delivered consistent value from our security spend, and we look forward to continuing to grow our partnership with them.” Whether customers need to speed their sales cycles, remediate after a breach, prevent future incursions, or respond to a third-party risk assessment, Cyvatar helps them achieve superior business outcomes every day. Click HERE to get started free and learn more about how Cyvatar is making cybersecurity effortless for every business. About Cyvatar Cyvatar is committed to effortless cybersecurity for everyone. As the industry’s first subscription-based, cybersecurity-as-a-service (CSaaS) company, it’s our mission to transform the way the security industry builds, sells, and supports cyber solutions. We empower our members to achieve successful outcomes by providing expert advisors, proven technologies, and a strategic process roadmap to guarantee results that map to their business drivers. Our approach is rooted in proprietary ICARM (installation, configuration, assessment, remediation, maintenance) methodology that delivers smarter, measurable security solutions for superior compliance and cyber-attack protection faster and more efficiently, all at a fixed monthly price. And because we’re a subscription, members can cancel anytime. Cyvatar is a global organization with operations around the world. Begin your journey to security confidence at cyvatar.ai and follow us on Facebook, Instagram, LinkedIn, Twitter, and YouTube. About ATX Venture Partners ATX Venture Partners is an early-stage venture capital firm specializing in the South-Central US. The firm’s seed and Series A investments focus on software-as-a-service, IoT, e-commerce, AI, frontier commercial technologies and mobile applications. ATX Venture Partners brings institutional-grade funding, process and rigor to early-stage venture capital investments, and is the partner to propel portfolio companies forward to larger growth capital. The firm was founded in 2014 and is based in Austin, Texas. Visit www.atxventurepartners.com, and follow them on Twitter, Facebook, and LinkedIn. Contact Details Cyvatar KC Higgins +1 303-434-8163 kc@cyvatar.ai ATX Ventures Meg Brigman +15127666462 meg@atxventurepartners.com Company Website https://cyvatar.ai/

June 17, 2021 07:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

New high-tech health screening technology to detect COVID-19 symptoms

Ontario Tech University

As a research leader in the ethical deployment of new technologies, Ontario Tech University is working with data sensory and ‘Internet of Things’ (IoT) company SmartCone Technologies to test a high-tech system capable of real-time multi-symptom screening for COVID-19. Making sense of scent loss Loss of smell is a common indicator of COVID-19 infection. Various research studies show loss of smell affects anywhere between 80 and 96 per cent of COVID-19-positive patients. U.S. agencies such as the Centers for Disease Control and Prevention, and the National Institutes of Health recognize and recommend smell testing for COVID-19 screening. SmartCone’s anonymous, two-step web-based health-screening process, dubbed SYMP2PASS, combines COVID-19 sense-of-smell testing with smart kiosks, thermal scanners, and other technologies to provide private, speedy, and reliable COVID-19 screening without accessing personal information: At home: In the privacy of their own home, a person uses their smart device to scan the QR code located on the company’s SYMP2PASS scent test packet, completes the smell test, and answers additional screening questions. They receive immediate confirmation of test results. In public spaces: If the person passes the at-home pre-screening, they will receive another QR code that provides a 24-hour ‘Day Pass’ to enter a SYMP2PASS Smart Kiosk set up at the entry point to the public venue they wish to access. The kiosk has a thermal camera with a sensor that tests for fever. The kiosk also uses mask-image recognition to ensure anyone entering a location is wearing a mask. SmartCone has a federal research contract with Innovation, Science and Economic Development's (ISED) Innovation Solutions Canada Sector to develop the technology. SYMP2PASS benefits SmartCone estimates onsite point-of-entry screening can reduce COVID-19 spread by up to 75 per cent, making the system ideal for any business or high-traffic location, such as professional sports stadium or a major amusement park. SYMP2PASS will: Help organizations follow current and future screening requirements mandated by various levels of governments and health authorities. Collate data from all access points and in-home measurements to ensure employers meet all privacy regulations. Support workplace contact-tracing capabilities. Warn participants of positive test results. Provide access control for visitors/guests and employees. Quotes “A crucial role the Ontario Tech University research enterprise plays is supporting lab-to-market initiatives. Our collaboration with SmartCone and Innovation, Science and Economic Development Canada is an exemplar of this role and will be a model for future product research, testing and validation of new technologies.” - Dr. Les Jacobs, Vice-President, Research and Innovation, Ontario Tech University "Innovation, Science and Economic Development was instrumental in being able to demonstrate our ability to fight COVID. They were very professional, organized and easy to work with. SmartCone is now selling to U.S. companies as a direct result of the demonstration." - Jason Lee, CEO, SmartCone Technologies About SYMP2PASS Powered By SmartCone SYMP2PASS, developed in conjunction with doctors and researchers, is the first anonymous end-to-end advanced health screening web process. Using our patent pending ScentsiBLE scent test paired with multi-symptom survey, SYMP2PASS will help reduce the spread of COVID and save businesses and countries millions of dollars. Learn more at www.symp2pass.com About SmartCone Technologies, Inc. SmartCone Technologies Inc. (SCTI) is a unique data sensory company that commercializes new Internet-of-Things (IoT) technologies powering a wide array of sensors, edge computing, sensor fusion and artificial intelligence (AI). TheSmartCone™ solutions have been used most recently in " Return to Work " solutions during the COVID-19 pandemic, as well as securing dangerous work sites, controlling bicycle lane traffic, managing vehicle fleets, smart warehouses, crowd control, and more. Visit us at www.thesmartcone.com Contact Details Tenille Houston +1 613-617-7467 tenille@thesmartcone.com

June 16, 2021 02:30 PM Eastern Daylight Time

Image
Article thumbnail News Release

NHS Test and Trace strengthen their cyber defences with Risk Ledger

Stockwood Strategy

NHS Test and Trace has selected British cyber security company Risk Ledger to manage cyber security risks in their supply chain as a proactive measure to mitigate the increasing risks the NHS and other critical national infrastructure organisations face from supply chain cyber-attacks. The Risk Ledger platform will give the UK government funded service all the tools they need to manage cyber security risks in their supply chain at speed for a low per-supplier cost - at least 60% cheaper than traditional solutions. Cyber security risks in the supply chain can include third parties failing to encrypt sensitive data when it is being transferred. NHS Test and Trace, established to track and help prevent the spread of the COVID-19 virus in England, will take advantage of Risk Ledger's key innovation which is its secure 'social network' allowing organisations to connect and share risk data securely, quickly, and easily. This gives organisations like NHS Test and Trace unparalleled visibility of their supply chain and a comprehensive set of data to identify, measure and mitigate supply chain security risks at scale. Major supply chain cyber security breaches at Solarwinds and Microsoft in recent months have put the challenge of securing supply chains at the top of the agenda for organisations around the world. Minister for Digital Infrastructure, Matt Warman MP said: “The government is working tirelessly to secure the nation online and grow the UK's £8.9 billion cyber security industry as we build back better from the pandemic. We're helping SMEs develop innovative products and services and it's great to see Risk Ledger, one of the firms we've supported, win this contract to protect the Test and Trace system and support the national effort against coronavirus.” Risk Ledger's client base includes organisations like BAE AI, City of London Police, Telenor, Schroder's Personal Wealth and ASOS. Risk Ledger CEO and Co-Founder Haydn Brooks said: "NHS Test and Trace is essentially the biggest new start-up in the UK healthcare market so we are delighted they have chosen to take advantage of our ability to provide enhanced visibility of their supply chain risks. I am proud we will be part of the effort to secure this incredibly important supply chain. "Healthcare organisations and their supply chains handle lots of highly sensitive data and have a high rate of data breaches. We have already seen during the COVID-19 pandemic that bad actors are actively targeting supply chains to access data and cause disruption” added Haydn Brooks. Risk Ledger is a rising star of the UK's growing cyber security scene having won competitions run by the UK Government's National Cyber Security Centre, the tech industry body TechUK and most recently a winner in the Department for Digital, Culture, Media, and Sport’s ‘Most Innovative UK Cyber SME of the Year’ competition in May. The company is also a member of the UK Government backed LORCA programme (London Office of Rapid Cybersecurity Advancement). About Risk Ledger Risk Ledger is a British company that manages cyber security risks in supply chains. Th process of supply chain security risk management ensures third parties who deliver critical services, have access to data, corporate networks, or any other status of business trust, maintain a good base level of cyber security controls to prevent bad actors using the third party as an attack vector. In 2019, Risk Ledger won the ‘Cyber Den’ competition at the 2019 CyberUK event run by the UK Government’s National Cyber Security Centre (NCSC) and the Department for Digital, Culture, Media and Sport (DCMS). At the time, Ian Levy, Technical Director at the NCSC said: ‘Our mission is to make the UK the safest place to do business online. We run the Cyber Den competition with DCMS to identify and provide a springboard for the most promising cyber security start-ups in the UK. Risk Ledger beat some excellent competition at this year’s Cyber Den event because their platform approaches supply chain security in a novel way that could revolutionise the way organisations understand the cybersecurity of their supply chains which is at the root of so many security incidents.’ Notable achievements - Risk Ledger was a finalist in the 'Most Innovative New Technology Award' category at the 2021 Water Industry Awards. - In March 2021, Risk Ledger won the South Summit Industry 4.0 innovation competition. - In May 2021, Risk Ledger was announced as a runner up in the Department for Digital, Culture, Media, and Sport’s ‘Most Innovative UK Cyber SME of the Year’ competition. Contact Details Risk Ledger Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://riskledger.com/

June 16, 2021 05:15 AM Eastern Daylight Time

Image
Article thumbnail News Release

Velocity Global commits $1M to First Descents to expand adventure programs for young adults coping with multiple sclerosis

Velocity Global

First Descents (FD) has announced a transformative $1 million contribution from Velocity Global to support the expansion of adventure programs for young adults living with multiple sclerosis (MS). Funds will support program development and help reach more than 1,000 MS participants over the next 5 years. “First Descents serves people first to fill a gap in psychosocial supportive care for young adults living with MS. Velocity Global is honored to support the expansion of these programs through this donation and volunteer efforts from our global team,” said Ben Wright, founder and CEO of Velocity Global. “I have witnessed the healing impact of First Descents programs firsthand, and am proud our company is in a position to advance this important work.” Velocity Global and First Descents share a special partnership that transcends financial support. The two Colorado-based companies began as office neighbors at INDUSTRY Denver in 2014. Over the years, Velocity Global employees have volunteered on First Descents programs and fundraised while competing in the Ragnar Snowmass Relay and the TransRockies Run. In 2018, Velocity Global contributed $150,000 to pilot MS programming which began with a whitewater kayaking experience in Tarkio, Montana. “Velocity Global’s support will help us to serve more than 1,000 young adults living with MS in the coming years while investing in vital partnerships with patient advocacy groups and neurology clinics nationwide,” observes Ryan O’Donoghue, CEO, First Descents. “We want MS patients to learn about First Descents closer to the time of diagnosis and know that we are here for them. Velocity Global’s leadership support will make this vision a reality.” The National MS Society indicates there are approximately 1 million people living with multiple sclerosis in the United States with approximately 10,000 new cases diagnosed each year. Typically, MS is diagnosed between the ages of 20 and 50, with a median age of diagnosis at 34. Young adults living with MS can experience significant physical, neurological and psychosocial changes that often disrupt important developmental milestones. In addition to the complexities of clinical treatments and lifestyle implications, the relapsing and progressive nature of MS can be daunting, and can result in significant psychosocial distress. According to the National MS Society, clinical depression ranks among the most common comorbidities associated with MS. These realities have been further exacerbated by the COVID-19 pandemic where prolonged social isolation and apprehension for the future have taken a significant toll. First Descents is working with several renowned patient advocacy groups, including the Multiple Sclerosis Association of America (MSAA) to reach more people coping with MS. “There is an important need to support young adult MS patients with age appropriate programming that can improve their outlook and quality of life,” observes Gina Ross Murdoch, CEO, Multiple Sclerosis Association of America. “Staying fit and active - especially with peers living with MS - can greatly benefit patients’ mental and physical health. We are excited to work with First Descents and Velocity Global on the launch of these programs.” First Descents’ all-inclusive programs are free of charge to participants. All programs ensure ADA lodging compliance, a tailored Wahls protocol nutrition program, and fully-accessible outdoor activities. Further, programs are designed with careful consideration to mitigate heat sensitivity, balance issues, and fatigue. Ultimately, First Descents creates an environment where young adults with MS can reclaim their physical agency, explore new activities, and nurture lifelong supportive peer relationships. ### ABOUT VELOCITY GLOBAL Velocity Global accelerates the future of work beyond borders. Its platform enables businesses to employ remote teams and expand internationally through global expertise, best-in-breed technology, and scale. More than 700 brands rely on its Employer of Record model and infrastructure, also called an International PEO (Professional Employer Organization), in 185 countries and all 50 United States to compliantly employ thousands of supported employees, access global talent, and grow revenue. Named a “Leader” in Global Employer of Record services by prominent analyst firm NelsonHall, Velocity Global is a strategic partner to its clients through additional comprehensive services including Immigration, Independent Contractor Compliance to assess a workforce, and Agent of Record (AoR) to streamline payments to contractors globally. Founded in 2014, the company is headquartered in Denver, Colorado, with regional headquarters in Amsterdam, Bogotá, and Singapore, with local employees in 16 countries. ABOUT FIRST DESCENTS First Descents (FD) is a leader in adventure-based healing. Through outdoor adventure, community building, and lifestyle development, FD improves long-term survivorship and quality of life for young adults impacted by cancer, multiple sclerosis, and other serious health conditions. Headquartered in Denver, First Descents has served more than 10,000 participants over the last 20 years. Beginning in 2020, First Descents launched programs for healthcare workers on the frontlines of COVID-19. All services are fully-adaptive and free of charge. A Guidestar Platinum-ranked nonprofit, First Descents has been recognized on CNN Heroes and Outside Magazine's Best Places to Work. RESOURCES: First Descents MS Program Page Contact Details Velocity Global John Hall +1 720-650-4348 johnhall@velocityglobal.com First Descents Ray Shedd +12034999633 ray.shedd@firstdescents.org Company Website https://velocityglobal.com/

June 15, 2021 07:02 AM Mountain Daylight Time

Video
Article thumbnail News Release

Secta Finance innovates the £10b private school fees model, making affordable finance options for parents

Stockwood Strategy

Fintech business Secta Finance has launched today to transform how private school fees are paid. Families are spending circa £10b every year to pay school fees for over 620,000 children and over the years there has been no innovation on the termly bill payments. Secta Finance has set out to change this and become an enabler for many more families considering private schooling but feel it is currently unaffordable. In collaboration with a number of financial institutions, Secta Finance has created a range of flexible and highly competitive finance plans that enable parents (and would-be parents) to spread the cost of private school fees over many years in a simple affordable way. The Secta Flexiplan enables parents to use the equity in their home to secure a facility that allows parents to draw funds flexibly within the first 5 years. Parents only pay interest on the amount they actually drawdown. If they don’t need to draw funds there is no cost. Parents can decide how much they draw; their monthly repayment amounts (subject to a minimum) and the term they repay over (up to 30 years). Also, there are no early repayment fees if they choose to repay in full. Below is an example* of how a Secta Flexiplan could be used to finance 5 years of private education. This example is based on one child, annual school fees of £15,000 per year and with the Secta Flexiplan being repaid over a period of 10 or 20 years. However, the amount borrowed, the term over which it is repaid and the monthly repayments can be adjusted to suit individual circumstances and preferences. Secta Finance has made it quick and simple for parents to get indicative quotes from their online platform. Thereafter they can engage with a qualified advisor to discuss their options and tailor a plan to suit their needs. Joe Hill, founder and CEO of Secta Finance commented: “How parents pay for private school fees is no longer fit for purpose. They are still paying large lump sums, sometimes, with expensive and inflexible means using credit cards or unsecured loans, that simply is not sustainable. Secta has set out to challenge this approach with a fresh lens and a clear pathway for parents to handle this significant expense. We want to create manageable and affordable finance solutions for school fees, much like the financial products people consider when buying a house or a car.” Contrary to popular belief, private education is not confined to the wealthy, but many middle class parents place a very high value on it and want to provide the benefits of a private education for their children. However, the costs can be prohibitive, especially for families with more than one child. Annual average school fees are in excess of £15,000 for day schools and in excess of £30,000 for boarding schools. Factoring in additional costs, a private education can cost an average of £325,600 per child for day school and £469,700 for boarders starting their schooling in 2019. Unsurprisingly, many parents find this a struggle. Research completed by Killik and Co suggests that private day school fees have increased by 403% since 1990. “Many parents make significant sacrifices to give their children a private school education. But it doesn’t have to be that way. It makes sense to have a solution whereby parents can spread the cost over a longer period of time if they wish (up to 30 years), to reduce the strain on their finances, but still be able to give their children a private education,” added Joe Hill. There are more than 2,500 independent schools in the UK catering for approximately 620,000 pupils. This represents about 7% of all UK school children and 18% of pupils over aged 16 years and older. The estimated school fee market value is approximately £11 billion. Secta Finance is working closely with schools who are keen to offer meaningful finance options for their parents. The company is also collaborating with independent financial advisors who are seeking flexible, efficient options for their clients. Parents are also directly engaging with the online platform to find out more about the options available to them. Looking ahead Joe Hill added: “We are creating opportunities for parents, for schools and for children. By offering finance solutions which are affordable, simple to understand, we will create a sustainable path for better outcomes. Our strategic aim is to expand the opportunity of private education to many more families and enable a sustainable relationship for parents and schools through the products that we offer”. ENDS *This is an indicative quote and does not constitute an offer or advice. Interest rate and solution terms will depend on your circumstances and the amount of the loan. Before you make a loan application, we will carry out a full review to establish your needs and preferences and if you meet the criteria, we will give advice and make a recommendation to you. All loans are subject to status. Please note that our product calculators show an indicative rate only and may not be suitable for you. Your home may be repossessed if you do not keep up with your repayments. About Secta Finance Our mission is to relieve the pressure of private school fees by providing innovative, affordable finance solutions to parents. In doing so, we bring the outstanding benefits of private education within the reach of many more families, everywhere. Secta Finance Limited is authorised and regulated by the Financial Conduct Authority. Contact Details Secta Finance Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.sectafinance.co.uk/

June 15, 2021 04:30 AM Eastern Daylight Time

Image
Article thumbnail News Release

The Impact of Hearing Loss and What You Can Do About It

YourUpdateTV

Hearing loss has been shown to affect nearly every dimension of human life, including physical, emotional and mental health. Recently, World Champion and Olympic Kayaker, Eric Jackson, participated in a nationwide satellite media tour to discuss his own battle with hearing loss and the importance of getting your hearing tested. A video accompanying this announcement is available at: https://youtu.be/0Ewdu9hNHF8 Hearing loss is the most common neurologic disorder in the world, affecting around 460 million people. According to the National Institutes of Health, about 37.5 million adults report some trouble hearing. Experts note that hearing loss is an undertreated condition, with an estimated 28.8 million U.S. adults with mild to severe hearing loss could serve to benefit from hearing aids. Untreated hearing loss brings higher risk of dementia, depression, memory loss, injury, and cognitive decline. There are several reasons for delay in addressing hearing loss, including recognizing and accepting that one may have hearing loss, having access to Hearing Care Professionals, and misperceptions associated with hearing aids. For Eric Jackson, hearing loss has been a lifelong battle. In 1966 at the age of two, Eric contracted Scarlet fever which caused him to completely lose his hearing in both ears. Eric is now 57 and his hearing has been partially restored over time; however, he still lives with severe hearing loss today and relies on hearing aids like ReSound ONE as necessary tools to help him communicate. All of ReSound’s hearing aids are designed with the person in mind, and is made to be discreet, comfortable, durable and functional. Hearing quality is the foundation for ReSound hearing aids, providing unmatched hearing quality, emulating the way humans hear sound. For more information, visit resound.com/online-hearing-test About Eric Jackson: Eric Jackson is a four-time world champion and an Olympian who has dominated the whitewater kayaking scene for the past three decades. Eric has received numerous accolades for kayaking, including two Everest Awards and the World Paddle Lifetime Achievement Award. He is also an entrepreneur, motivational speaker and hosts his own popular videos on YouTube. In 1966 at the age of two, Eric contracted scarlet fever which caused him to completely lose his hearing in both ears. Eric is now 54 and his hearing has been partially restored over time; however, he still lives with severe hearing loss today and relies on hearing aids and lipreading as tools to help him communicate. Eric has never let hearing loss stop him from enjoying life and pursuing his ambitions. Today, Eric spends his free time helping others achieve their goals, coaching the winners of almost every gold medal winner in freestyle kayaking over the past 15 years, including his two children. Eric’s son, 27-year-old Dane, a world champion kayaker himself, also lives with severe hearing loss which he has had since birth About YourUpdateTV: YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

June 11, 2021 03:00 PM Eastern Daylight Time

Video
Article thumbnail News Release

Centre for Neuro Skills Sets June 24 as Grand Opening for New Austin, Texas Clinic

Centre for Neuro Skills

The Texas Brain Injury Alliance reports that 144,000 Texans sustain a traumatic brain injury each year - one every 4 minutes. The Texas Department of State Health Services reports that approximately 72,500 Texas residents have strokes each year that require hospitalization. Now, more help is on the way. Centre for Neuro Skills (CNS), a premier provider of treatment for traumatic and acquired brain injury, announced the grand opening date of its new clinic in Austin, Texas. The clinic will celebrate with an invitation-only open house on Thursday, June 24. Former CNS patients Justin Glick and Megan Guerra are guest speakers who will share their rehabilitation stories. The 17,000-square-foot facility is located at 14425 Falconhead Blvd., Building F, Suite 200, Austin. A virtual tour of the new facilities is available. To access the tour, please click here. The Austin clinic is CNS’ fourth location in Texas, joining Dallas, Fort Worth and Houston. CNS also treats patients at three facilities in California. All CNS clinics offer a continuum of care approach to therapeutic rehabilitation and disease management services for those recovering from acquired and traumatic brain injuries. “No two brain injuries are the same,” said CNS’ Chief Medical Officer, Dr. Matthew Ashley. “What sets CNS apart is our whole team focus on patients and their caregivers. This new clinic will allow us to provide localized quality care to brain injury patients in Austin and Central Texas, which will ensure better recovery. Our goal is to maximize independence and improve quality of life.” Patient Success Story – Justin Glick Former CNS patient Justin Glick and his wife Caroline relocated to Austin from Los Angeles in 2020. They have since had their first baby, Sienna. After sustaining a traumatic brain injury at work, Justin sought treatment at the CNS Los Angeles clinic. He made a remarkable turnaround in just 47 days. Justin had spent his career in a highly specialized profession – the collecting and selling of rare coins, jewelry and watches. He’s now a real estate agent with Coldwell Banker in Austin. According to Justin, “the Centre for Neuro Skills has an amazing team that helped me literally get back on my feet and back to work. Caroline and I moved to Austin last year and absolutely love it. And now, we have our friends from CNS as neighbors. Austin is fortunate to have such an outstanding resource for brain injury rehabilitation.” Rehabilitative Technology Technology and advanced care systems at the Austin Clinic include: The ZeroG® Gait and Balance System, which helps patients relearn to walk, sit, stand, balance and improve gait. The Bioness Integrated Therapy System, which addresses vision, safety and motor balance training; the system supports returning to work and driving. The Independent Living Scale tracking system, which monitors patient progress. Tablets to record/integrate patient data in real time for analysis. Patient web portal for 24/7 secure access. Dedicated physician space, including a medical exam room, secured medication room and a nursing suite. Dedicated area for behavior analysis, including a meditation/quiet room. Patient and staff kitchen; computer center and offices for case management and administration. COVID-19 Safety Staff, patients and visitors are required to wear a mask at all times when in the clinic and common areas of residential homes. Clinic and residential visitors will have their temperatures taken upon entry. CNS clinics, homes and facilities observe CDC guidelines. About Centre for Neuro Skills Centre for Neuro Skills is an experienced and respected world leader in providing intensive rehabilitation and medical programs for those recovering from all types of brain injury. CNS covers a full spectrum of advanced care from residential and assisted living to outpatient/day treatment. Founded by Dr. Mark Ashley in 1980, CNS has seven locations in California and Texas. For more information about Center for Neuro Skills, visit: https://www.neuroskills.com/, Facebook, Twitter, LinkedIn, YouTube. For a video overview of CNS, visit: https://youtu.be/Jwqve9gWtEw Media, please note: Visual assets, including photos, are available. To request an interview with CNS leadership, clinical staff or patient guests at or before the Grand Opening, please contact Robin Carr at (415) 971-3991 or CNS@landispr.com. Contact Details Landis Communications Inc. Robin Carr +1 415-971-3991 CNS@landispr.com Company Website https://www.neuroskills.com/

June 10, 2021 10:42 AM Pacific Daylight Time

Image
Article thumbnail News Release

NextFerm Technologies Announces Successful Pilot for Industrial-Scale Production of ProteVin™, its Proprietary Vegan Protein

NextFerm Technologies Ltd.

NextFerm Technologies (TASE:NXFR), a Food-tech company developing ProteVin™, a vegan, non-GMO, yeast-based protein alternative, announced that it has successfully completed an industrial production pilot for ProteVin™. The successful pilot is the first of three milestones towards commercial production and launch of ProteVin™, planned in 2022. The two additional milestones are first, generating initial demand from the market and engagement with a first customer by the end of 2021; and second, entering into a production agreement with a subcontractor. As part of the pilot, which was conducted at production facilities in the US, the industrial production of the protein was examined while preserving the same characteristics that were achieved in the laboratory scale. Analysis of the results by independent laboratories, an internal team taste testers and a potential customer, showed that ProteVin™ successfully achieved all the pilot's objectives. Boaz Noy, Chief Executive Officer of NextFerm, said, “The successful industrial pilot of ProteVin™, marks an important achievement that brings us significantly closer to the planned commercial production and launch of ProteVin™ in 2022. The fast-growing alternative protein market is estimated at $13 billion, with an annual growth rate of 10%. The strong need for innovation by leading players in the food industry is for the protein itself, the raw material that is the foundation for all animal-derived food alternatives. The successful pilot reflects the outstanding value proposition of ProteVin™ as an alternative to animal-derived protein, with neutral flavor, the most important parameter for food manufacturers. This makes it accessible to a wide array of products such as milk and dairy substitutes, meat substitutes and additional categories such as infant nutrition, adult nutrition, and sports nutrition. Furthermore, for the first time, we bring the market a vegan protein with nutritional value that is higher than other plant-based proteins and that is comparable to animal-derived proteins. The nutritional advantage of ProteVin™ over other sources of plant-based proteins can be seen in its amino acid profile, which provides more essential amino acids (EAA) and more branched-chain amino acids (BCAA) and has better digestibility.” Mr. Noy Concluded, “We have recently begun sending commercial samples of ProteVin™ to potential customers worldwide. On the production side, we are in discussions with several potential subcontractors, in order to launch the product in 2022, as planned, and look forward to update our investors on our progress.” 1 st Target - Meeting the parameters determined that define the product: In tests performed by an independent laboratory, ProteVin™ met all parameters defined, including concentration of the protein, composition of amino acids, digestibility, light color, a product free of contaminants and allergens, and its compliance with food regulations and other quality parameters. 2 nd Target - Compliance with taste, flavor and odor requirements: ProteVin™ achieved neutral taste, flavor and odor requirements, without typical aftertaste and odor of various types of plant-based proteins. 3 rd Target - ability to supply samples of ProteVin™ for customers' approval: As part of the pilot, NextFerm produced a quantity of the protein sufficient to supply samples in the amount required for approval by potential customers. Customer testing includes integrating the protein in the prototype of their products, which is an essential step towards a commercial agreement with a customer. To the best of the company's knowledge, other than ProteVin™, there is currently no other protein alternative on the market with the same nutritional value and amino acid composition as animal-derived protein, and which has a neutral taste and flavor, with no aftertaste. In terms of regulation, ProteVin™ can be marketed in the US, Europe and other countries. About NextFerm Technologies NextFerm Technologies, traded on the Tel Aviv Stock Exchange (TASE:NXFR) is a food-tech company engaged in the research, development, manufacturing and marketing of innovative, functional and vegan yeast-derived, non-GMO protein alternatives for various applications in the food and food supplement markets and the growing market for animal-derived protein alternatives. NextFerm's flagship product is ProteVin™, a vegan yeast-derived protein alternative with nutritional value that is similar to animal-derived protein and a neutral flavor with no aftertastes that are typical of plant-based protein. ProteVin™ is designed for a variety of categories in the alternative protein market, which is estimated at $13 billion, with an annual growth rate of 10%, including the alternative meat market, milk alternatives and powder formulas for the infant nutrition market, for the wellbeing market and the market for athletes. NextFerm is gearing up for commercialization of the product in the US in 2022. Another product currently being sold is Astaferm®, an innovative astaxanthin-based antioxidant derived from yeast that has been sold in the US since the end of 2020 through well-established and leading brands in the food supplement market in the US. The company has additional products which have been licensed to Lallemand, a global giant focused on yeast. For more information, visit the NextFerm website at: www.nextferm.com Legal Notice Regarding Forward-Looking Statements This announcement also includes forecasts, projections, assessments, estimates and other information which refer to future events and matters, the realization of which is uncertain and not exclusively under the Company’s control (forward-looking information). The main facts and data used to support this information are facts and data regarding the current position of the Company and its businesses (including the scope of sales and levels of profitability, manpower, commercial engagements and more), facts and data regarding the current global position of the Company’s operating segments (including industry-specific financial developments, environmental regulatory developments, the competitive environment, technological developments, the reinsurance market and more), and macro-economic facts and data (including the economic situation both in Israel and around the world, yields in the capital markets, social and state developments and more), all as known by the Company when publishing this announcement. The forward-looking information included above in this announcement is significantly based upon, in addition to the existing information held by the Company, on the Company’s current assessments and expectations of future developments vis-a-vis each one of the aforementioned parameters, and the interconnectedness of each one of these developments. The Company has no certainty that its forecasts and assessments will indeed eventuate, and the Company’s operating results may be materially different than the results assessed or implicit based on that set forth above, inter alia, as a result of a change in any of the aforementioned factors. Contact Details NextFerm Technologies Ltd. Yossi Ohana - Chief Financial Officer +972 54-771-5893 yossio@nextferm.com Investor and Media Contact Meirav Gomeh-Bauer +972544764979 meirav@bauerg.com Company Website https://www.nextferm.com/

June 08, 2021 11:30 AM Eastern Daylight Time

1 ... 186187188189190 ... 216